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It has long been speculated that many autoimmune diseases are the result ofin-
fectious agents. Examples of autoimmune diseases believed to have an infectious
"trigger" include rheumatic heart disease (group A streptococcus) (1), celiac disease
(adenovirus), ankylosing spondylitis, and Reiter's syndrome (klebsiella, yersinia, and
shigella) (2). Forexample, in rheumatic heartdisease, group A streptococcus, which
causes this disease, hasbeen shown tohave crossreactiveantigens with valvular tissue.
Thus, by molecular mimicry, this pathogen sets up the autoimmune response that
leads to the destruction ofheart valves (1). Despite the importance ofunderstanding
autoimmune diseases, there are few experimental models of autoimmune disease
induced by an infectious agent.
Chagas' disease, caused bythe intracellular parasite Trypanosomacruzi, is an excel-
lent model for autoimmune disease induced by an infectious agent. The chronic
disease is characterized by rich inflammatory infiltrates in myocardial and nervous
tissues, withfew, ifany, demonstrable parasites. Autoantibodies can befound in sera
from Chagas'patients (3, 4). Selected mAbs to T . cruzihave been found to crossreact
with nervoustissue antigens (5-8). Tcellsdirected againstcardiacandnervous tissue
antigens have been found in mice with experimental Chagas' disease (9-13). Tcells
directed against T . cruzi antigens which crossreact with nervous tissue, have been
found to recreate nervous tissue pathology when transferred to naive animals (12,
13). This has ledtothe hypothesis that T. cruziantigenically mimics host tissues that
are damaged by inflammatory cells in chronic disease. It is important to charac-
terize these crossreactive antigens in order to understand the breakdown of immu-
noregulation that allows for autoimmunity. Yet, the molecular nature ofcrossreac-
tive antigens in T . cruzi and nervous tissues is still poorly understood.
We used DNA cloning techniques to characterize a T . cruzi surface antigen that
crossreacts with mammalian tissues. We have cloned DNA from T . cruzi that ex-
pressesaproteincorrespondingtoa 160ADprotein foundonthesurface ofthetrypano-
some, overlying the flagellum. Antibodies to this protein crossreact with a 48-kD
mammaliannervoustissue protein. Thus, theantigenis acandidate antigen forauto-
immune mimicry leading to nervous tissue pathology.
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Materials and Methods
T . cruzi.
￿
T. cruzi CL strain, used throughout, was "subclone three" described in reference
14, and was maintained in liver infusion/tryptone (LIT) medium with 10% fetal bovinemedium
as the epimastigote form. Trypomastigotes were obtained from culture supernatants of rat
3T3 cells infected with trypomastigotes and commonly contained 10-40% amastigote forms.
8-wk-old female C3H/HeJ mice (The Jackson Laboratory, Bar Harbor, ME) were infected
with T . cruzi by intraperitoneal injection of 5 x 104 tissue culture-grown trypomastigotes.
Infection was confirmed by finding trypomastigotes in blood films at 5-8 d after infection,
and mice were considered chronically infected at 3 mo after infection. Chronically infected
mouse sera were absorbed with 20% (vol/vol) formalin-fixed Escherichia coli.
DNA Cloning andAnalysis.
￿
DNA was selected by eluting 4-8 kb sonicator sheared T. cruzi
epimastigote DNA from an agarose gel, repairing, and cloning into X GT11 using standard
techniques (15, 16). The gF1-160 DNA clone described here was one ofmany clones expressing
fusion proteins reactive with chronically infected mouse sera. The gF1-160 insert DNA was
subcloned into Bluescribe plasmid (Stratagene Inc., LaJolla, CA). Probes for Northern hy-
bridization were agarose gel-purified restriction fragments of CsCl-purified plasmid DNA,
labeled by random priming in the presence of a-[32P]CTP (16, 17). RNA for Northern hy-
bridization was purified by cesium chloride gradient centrifugation of guanidinium-lysed
trypomastigotes and epimastigotes. 5 pg per lane was subjected to electrophoresis in formal-
dehyde agarose gels and transferred onto nylon membranes (Genescreen Plus; New England
Nulear, Boston, MA) (16). Northern hybridization was carried out at 42°C using standard
techniques (16), and washed at high stringency (65°C, 0.1 x SSPE).
The F1-160 DNA was subcloned into a plasmid (Glutagene; a generous gift of G. F. Michell,
D. B. Smith, and the AMRAD Corp., Ltd., Abbotsville, Australia) expressing the FL-160
protein as a fusion to Schistosomajaponicum glutathione-S-transferase (GST)' (18). This recom-
binant fusion protein was purified from isopropylthiogalactoside (Sigma Chemical Co., St .
Louis, MO) induced bacterial lysates using affinity columns of glutathione-agarose (Sigma
Chemical Co.) (18).
Antibody Techniques.
￿
100 pg ofaffinity-purified recombinant antigen emulsified in Freunds'
adjuvant (first complete, then incomplete) was injected monthly intramuscularly in a NZW
rabbit. After three boosts, the resultant antiserum was affinity purified by passing 15 cc of
sera over a 5-ml column of5 mg ofrecombinant GSTcyanogen bromide linked to Sepharose 4B
(Pharmacia Fine Chemicals, Piscataway, NJ) to deplete the antiserum ofanti-GST antibodies.
The column was washed extensively and the anti-GST antibodies (used as a control in many
experiments) were eluted with 3 M NH4SCN in PBS. Then, anti-Fl-160 antibodies were pre-
pared similarly from the anti-GSTdepleted serum using a column of 3 mg of F1-160-GST
fusion protein linked to CNBr-Sepharose 4B. T . cruzi and tissue extracts were prepared as
previously reported (13). ELISAs were performed by coating plates with 10 pg/ml ofantigens
in 50 mM tris, pH 9.3, overnight at 4°C, quenching with 1 mg/ml BSA, exposing to anti-
bodies, components ofan anti-rabbit avidin-biotin-peroxidase kit (Vector Laboratories., Inc.,
Burlingame, CA), developed with 2.2'-Azino-bis(3-ethyl)-azoline-6-sulfonic acid (Sigma Chem-
ical Co.), and read on an automated ELISA reader (BioTek Instruments, Inc., Burlington, VT).
Western blots were performed using PAGE according to Laemmli (19) and electroblotted
onto nitrocellulose (Schleicher & Schuell, Inc., Keene, NH) (20), treated with 5% nonfat
dry milk, exposed to antibodies, and developed with avidin-biotin-peroxidase and diaminoben-
zidine (Sigma Chemical Co.) or with 1251 protein A (New England Nuclear). Immune
staining was performed on tissues and parasites fixed in 4% paraformaldehyde/PBS at 4°C,
exposed to 1 mg/ml BSA, antibodies, and then goat F(ab')2 FITC-labeled anti-rabbit IgG
(Tago Inc., Burlingame, CA) or anti-rabbit avidin-biotin-peroxidase developed with di-
aminobenzidine. Parasites were surface labeled and tissue extracts were labeled with 1251
using Iodogen (Pierce Chemical Co., Rockford, IL) bound to glass tubes (21). Parasites were
lysed with 0.5% NP-40/PBS10.5 mM PMSF/0.5% aprotinin (Sigma Chemical Co.). Immu-
' Abbreviations used in thispaper: /3-gal, E. coli fl-galactosidase encoded by X GT11; CIMS, chronically
infected mouse sera; GST, S japonicum glutathione-S-transferase.VAN VOORHIS AND EISEN
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noprecipitation wasaccomplished by incubation with 1 Rg/ml antibody, followed by protein
A-Sepharose 4B (Pharmacia Fine Chemicals) .
Results
We began ourstudiesby makingan expression library ofrandomly sheared T . cruzi
DNA in X GTll and screening with sera from chronically infected mice. This sera
has been previously shown to react with mammalian tissues, as well as T . cruzi an-
tigens . From nine clones orginallychosen,we have focussed ourstudies on one, gF1-160,
which codes foracrossreactiveprotein.We have not yet characterizedthe othereight
to know, if they too, code for crossreactive proteins . We will show that the gF1-160
DNA insert produces a recombinant protein (F1-160) that corresponds to a 160-kD
protein found on the surface ofT . cruzi trypanosomes, overlying the flagella. Anti-
bodies directed to F1-160 crossreact with nervous tissues found at sites of chronic
pathology, recognizing a 48-kD protein.
gF1-160InsertEncodes aPolypeptide Recognized by Chronically InfectedSera .
￿
The gF1-160
insert in the X GT11 vector produces a fusion protein of 180 kD that reacts with
chronically infected mouse sera (CIMS) (Fig. 1) . Of this, 118kD is 0-gal and the
remaining 62 kD of the fusion protein is encoded by the F1-160DNA. /3-gal or other
products of theE . coli lysate did not react with CIMS. Uninfected mouse sera does
not react with F1-160 fusion protein (not shown) .
To purify the F1-160 protein, the insert was subcloned into Glutagene, aplasmid
vector that expressesDNA fused to SjaponicumGST (18) . This allowed purification
of the F1-160-GST fusion protein from bacterial lysates in a single step by affinity
chromatography on glutathione-agarose. By Coomassie staining (Fig . 1), there are
two major polypeptides ofF1-160-GST with molecular masses of 88 and and 83 kD,
whereasthe recombinantGSTprotein is 27 kD. This agrees with the AGT11-derived
estimate ; that is the F1-160 DNA codes for an ti60-kD polypeptide. Fig. 1 shows
CIMS reacts with the F1-160-GST fusion protein . There are a number of smaller
molecularweight bandsin thepurified F1-160-lysate that are immunoreactive as well .
Theselikely represent degradationproducts. Affinity-purified anti-Fl-160 antibodies
FIGURE 1 . Western blot of recom-
binant proteins . The two left lanes
are 50 Wg/lane isopropylthiogalacto-
side-induced E . coli RY1089 lysate of
XGT11 with gF1-160 insert (F1-160-5-
gal) andno insert (S-gal) reacted with
chronically infected mouse serum
(1 :200 dilution). The six right lanes are
2 fig/laneGSTrecombinant proteins,
affinity purified on glutathione-aga-
rose, either expressed with gF1-160 in-
sert (F1-160-GST) or no insert (GST).
These lanes are stained with coomassie
brilliant blue or reacted with chroni-
cally infected mouseserum or affinity-
purified rabbit anti-Fl-160 antibodies
(1 ug/ml) or rabbit preimmuneserum
(1 :100)preabsorbedwithE . coli, and all
are developed with the avidin-biotin-
peroxidase-diaminobenzidine system.644
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react with F1-160-GST, but notGST alone (Fig. 1) . Affinity-purified anti-GST anti-
bodies react with both F1-160-GST andGST (not shown) . Preimmune rabbit sera
does not react with either recombinant protein (Fig . 1) .
Anti-Fl-160 Antibodies Immunoprecipitate a 160-kD Surface Protein that Is Associated with
the Flagellar Apparatus of Trypomastigotes. We used indirect immunofluorescence to
demonstrate the antigen on parasites . Affinity-purified anti-Fl-160 antibodies stain
T . cruzi trypomastigotes linearly along the entire length of the flagellum (Fig . 2) .
Theanti-Fl-160 antibodies did not stainepimastigotes (the insect form)or amastigotes
(the intracellular form) . Control anti-GST antibodies gave no staining with any of
these forms .
The anti-Fl-160 also gave strong immunofluorescence with infected 3T3 cells (Fig .
2), butnot with uninfected cultures . Most of thefluorescence appeared to come from
the surface of the cells, and appeared in a beaded or granular fashion . Interestingly,
FIGURE 2 .
￿
Indirect immunofluorescence shows anti-Fl-160 antibodies react with trypomastigote
flagellarmembranesandT . cruzi-infected 3T3 cells. Parasites and cells arestained with 1 Wg/ml
anti-Fl-160 or anti-GST andFITC-F(ab')z anti-rabbit IgG. (A) T . cruzi trypomastigotes with anti-
F1-160 . (B) T . cruzi trypomastigotes with anti-GST . (C) T, cruzi epimastigotes with anti-Fl-160 .
(D) 3T3 cells infected with T . cruzi trypomastigotes after 5 d in culture .VAN VOORHIS AND EISEN
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all cells in the infected culture stained, even cells that appeared to have no parasites
intracellularly No immunofluorescence was seen with control anti-GST antibodies .
It seems likely, therefore, that the F1-160 antigen is absorbed onto uninfected cells .
Anti-Fl-160 antibodies bind or immunoprecipitate a 160-kD surface protein on
trypomastigotes . Fig . 3 shows aWestern blot developed with anti-Fl-160 antibodies,
showing a broad band at 160 kD in the trypomastigote lysate . This 160-kD band
was not found with control anti-GST antibodies (Fig . 3), or by anti-Fl-160 antibodies
on uninfected 3T3 cell lysates (not shown) . In other experiments (not shown), the
anti-Fl-160 antibodies didnot bind epimastigote lysates . Anti-Fl-160 antibodies, selected
from chronically infected mouse sera with F1-160-a gal fusion proteinbound to nitrocel-
lulose, also reacted with the 160-kD protein in trypomastigote lysate Western blots
(not shown) . A 160-kD protein was immunoprecipitated from lysates of t25I surface-
labeled trypomastigotes with anti-Fl-160 antibodies (Fig. 3), demonstrating the pro-
tein to be on the surface. Control anti-GST antibodies gave no detectable precipitation .
Anti-Fl-160 Antibodies Crossreact withMammalian Nervous Tissues.
￿
We first detected
crossreactivity of anti-Fl-160 antibodies with mammalian antigens in the ELISA.
Fig . 4 shows that affinity-pure anti-FI-160 antibodies react strongly with F1-160-GST
fusion protein, but not withGST, as expected . Anti-GST antibodies react with both
oftheserecombinant proteins becauseboth containGSTepitopes . Anti-FI-160 anti-
bodies react with T . cruzi lysate as expected, but also crossreact with nerve and brain
lysates . Anti-Fl-160 antibodies do not react with cardiac lysates . Anti-GST antibodies
do not react with T . cruzi, or any of the tissue lysates .
By immunoperoxidase staining, we were able to confirm and localize this cross-
reactivity to processes in nerve and brain (Fig. 5) . The processes seen in brain were
in highest density in white matter. The same pattern of staining was seen by im-
munofluorescence. Double immunofluorescent staining with mouse mAbs to 68-
and 130-kD neurofilaments and rabbit antibodies to F1-160 reveals similar localiza-
FIGURE 3 .
￿
Autoradiogram of Western blot
andimmunoprecipitation reveals trypomasti-
gote FI-160 protein . Thetwo left lanesare 50
Ag/lane oftrypomastigote lysate on 10% poly-
acrylamide SDS gel, Western blotted to nitro-
cellulose, andreacted with 2 N.g/mlanti-GST
or anti-Fl-160 antibodies . The two right lanes
are surface- 1251-labeled trypomastigote ly-
satesimmunoprecipitated with anti-GST or
anti-Fl-160 antibodies and run on a 4-12%
gradient polyacrylamide SDS gel .646
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FIGURE 4 .
￿
ELISA shows anti-FI-160 antibody
crossreactivity with nerveand brain, but not heart
tissue . Bars represent absorbance foundwith each
tissue bound to ELISA microwells, reacted with
2 pg/ml rabbit anti-Fl-160 or anti-GST antibodies,
and developed with avidin-biotin-peroxidase-
ABTS system .
tion in nerve and brain, though some processes in brain stained with anti-Fl-160
antibodies appear not to stainwith antineurofilament antibodies (not shown). Human
sciatic nerve also stained with anti-Fl-160 antibodies, but not anti-GST antibodies
(not shown) . No staining by anti-Fl-160 antibodies was observed on skeletal muscle,
liver, kidney, or cardiac tissues .
Immunoperoxidase staining revealed anti-Fl-160 antibodies react with the myen-
teric plexus ofneurons between the smooth muscle layers ofmouse ileum (Fig. 5) .
This is particularly interesting because the myenteric plexus is destroyed in chronic
disease, leading to the characteristic pathology ofmegaesophagus and megacolon.
The antibodies recognizing determinants in nervous tissues were confirmed to
be the same as those reacting with T . cruziby absorption studies . Absorption of 0.3
gg/ml anti-Fl-160 antibodies with 50 Nzg/ml nerve extract (but not cardiac extract)
abrogated immunofluorescence of trypomastigotes and absorption of0.3 hg/ml anti-
F1-160 with 50 NAg/ml trypomastigote extract (but not epimastigote extract) abrogated
immunofluorescence with sciatic nerve (not shown) .
Anti-Fl-160Antibodies Recognizea 48-kD Protein in BrainandSciatic Neroe Extracts.
￿
West-
ern blots and immunoprecipitation demonstrate the molecular mass of the cross-
reactive nervous tissue protein recognized by anti-Fl-160 antibodies . A 48-kD band
was seenon Western blots ofbrain extracts exposed to anti-Fl-160 (Fig. 6) . This band
wasnot seen in liver, kidney, or heartextracts . A48-kDband was also seen by immu-
noprecipitation of "'I-labeled sciatic nerve extract with anti-Fl-160 antibody (not
shown) . This band was not seen with control immunoprecipitations with anti-GST
antibody andlabelednerveextract, or with anti-Fl-160 antibody and labeled cardiac
extract . Thus, a nervous tissue-specific 48-kD protein is recognized by anti-Fl-160
antibodies .
Molecular Expression ofF1-160RNA.
￿
We analyzed the gF1-160 insert to determine
what part of it is transcribed and translated . The gF1-160 DNA insert is 5 kb and
the restrictionmap is shown in Fig. 7 . Based on the 60-kD size of thegF1-160-encoded
contribution to the fusion proteins (see first section of Results) and assuming an
average molecular mass of 110 daltons per amino acid, -550 amino acids are ex-
pressed from the F1-160 insert . This means that 1,650 by are expressed, or about
one-third of the total F1-160 insert .
Northern analysis revealed theexpression of gF1-160-hybridizingRNA to be differen-VAN VOORHIS AND EISEN
FIGURE 5 .
￿
Immunoperoxidase staining with anti-FI-160 antibodies demonstrates crossreactivity
with processes ofnerve and brain and the myenteric plexi of gut . a, c, e, and g are exposed to
2 pg/ml anti-Fl-160 antibodies and b, d, f, andhare exposed to 2 pg/ml anti-GST All are devel-
oped with avidin-biotin-peroxidase system and counterstained with hematoxylin . aand b show
mouse sciatic nerve in longitudinal section, where anti-Fl-160 reactivity is seen to run longitudi-
nally along the processes of the nerve . c and d are high-power magnifications of mouse sciatic
nerve in partial crosssection (lower sight) showing anti-Fl-160 antibodies reactivity underneath
the myelin sheath, within the nerve processes . e andfshow reactivity of anti-Fl-160 antibodies
with many processes in mouse brain, most cut in cross section, but occasionally seen longitudi-
nally fora short distance.gand h show anti-Fl-160 antibodies react with myenteric plexi ofneurons,
found between two perpendicularly oriented smooth muscle layer in mouse ileum.
647648
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FIGURE 6 .
￿
Autoradiograms of Western
blots ofbrain extract demonstrate anti-Fl-
160 antibodies crossreact with a48-kD pro-
tein . 100 Ftg/lane of tissue extracts from
brain, heart, andkidney were runon 10%
polyacrylamide SDS gels, transferred to
nitrocellulose, and exposed to 2 ug/ml
affinity-pure rabbit anti-Fl-160 or anti-
GST antibodies .
FIGURE 7 .
￿
Restrictionmap of gF1-160 DNA and Northern Analysis of gF1-160 fragments . The
restriction enzyme map of gF1-160 is shown with the transcriptional direction in the recombinant
expression vectors. The probes, shown as dark bands, were hybridized to Northern blotted RNA
from epimastigotes (Epi, at 3 ,ug/ln) and trypomastigotes (Trypo, at 1 Wg/ln). A probe ofT . brucei
tubulin cDNA acts as a control to show the epimastigote RNA is intact .VAN VOORHIS AND EISEN
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tiation specific. The gF1-160 probe hybridizes to a single 4.5-kb band present in
trypomastigote RNA, but not epimastigote RNA (Fig. 7). This is consistent with
the finding that anti-Fl-160 antibody reacts only with trypomastigotes, and not
epimastigotesor amastigotes. Control tubulin probehybridizes to both trypomastigote
and epimastigote RNA, demonstrating the epimastigote RNA to be intact. In ex-
periments not shown, we have found the 4.5-kb gF1-160-hybridizing RNA to be in
the poly(A)+ fraction, consistent with it being mRNA. Thus, the absence of F1-160
antigen of epimastigotes is likely due to transcriptional regulation. That amastigotes
express gF1-160-related messages cannot be excluded, given that trypomastigote RNA
is contaminated with amastigote RNA. Nonetheless, the lack of epimastigote anti-
genexpression correlating with lack oftranscription, and lack of amastigote antigen
expression, suggests that thegF1-160-hybridizing mRNA is expressedin adifferenti-
ation-specific manner solely in the trypomastigote form.
The finding that gF1-160 DNA hybridizes to a 4.5-kb RNA is in keeping with the
160-kD molecularmass ofthe trypomastigote protein. An mRNA of that size would
be able to code for a protein of at least 166 kD.
Discussion
We have shown that a T . cruzi DNA clone (gF1-160) expresses a recombinant pro-
tein that correspondsto a 160-kD flagellum-associated surfaceprotein oftrypomasti-
gotes that is recognized by sera from chronic infection. Furthermore, antibodies
directed to epitopes on this recombinant protein crossreact with nervous tissue in
thecentralnervous system, peripheral nerve, and myenteric plexi, andin the former
two tissues, react with a 48-kD protein. The identity of this protein is unknown,
but is under current investigation.
Chronic T . cruzi infection can lead to nervous tissue pathology, most typified by
megaesophagus andmegacolondisease, caused by the destruction ofmyenteric plexi
in the gut. Autoimmune processes have been hypothesized to cause this pathology
in chronic T . cruzi infection. T . cruzi antigens that antigenically mimic mammalian
nervoustissue antigens have been implicated in the generation of autoimmunity by
molecular mimicry. The best data supporting this hypothesis is the T . cruzi-reactive
T cell lines, which also proliferate with nervous tissue antigens, can passivelytransfer
pathologic damage to naive mice (12, 13). Since the antigens used to generate these
T cell lines were notwell defined, it is difficult to studythe generation ofthis autoim-
mune response. F1-160 is a protein that is a candidate antigen for this autoimmune
response. We have had difficulty immunizing mice with this antigen to obtain a sero-
logic response, despite theuse ofadjuvants andmultiple immunizations. This raises
two points. First, the parasite may use antigenic mimicry to help blunt the immune
response. Second, it seemslikely that to generate autoimmunity, both antigenic mim-
icry plus breakdown of immune regulation preventing response to self-antigens are
needed. This breakdown of immune regulation may occur during the acute infec-
tion, where massive polyclonal lymphocyte proliferation has been documented (22).
A similar massive polyclonal lymphocyte proliferation has been correlated with the
generation of autoimmune responses in genetically susceptible mice (23, 24).
Once the autoimmune response to F1-160 is established, perhaps the lack of my-
elinationof themyentericplexi, exposing theirantigens to circulating immune cells,
explains the particular sensitivity ofmyenteric plexito immune destruction in chronic650
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Chagas' disease. We are beginning to study the cellular immune response to the
F1-160 antigen to help determine its role in pathology.
Several findings extend our results to human disease. First, the anti-Fl-160 anti-
bodies bind to human sciatic nerve, confirming this crossreactive antigen is present
in human tissues. Second, humans make antibody to the F1-160 antigen when in-
fected. In preliminary experiments, we have found that approximately one-third
of T . cruzi-infected individuals have demonstrable antibody to Fl-160. ELISA titers
of 1 :1,600 have been detected in some chronically infected individuals. Geographi-
cally matched uninfected controls do not have antibodies to Fl-160. Thus, humans
are induced by infection to recognize this crossreactive antigen. We are now col-
lecting enough specimens to attemptto correlate reactivity to F1-160 with diseasestate.
The F1-160 protein is limited to the trypomastigote form of T. cruzi as evidenced
by the fact that (a) Northern analysis shows hybridization of F1-160 DNA to trypo-
mastigote RNA, but not epimastigote RNA; (b) immunofluorescence with anti-Fl-
160 antibodies shows reactivity with trypomastigotes, but not epimastigotes or
amastigotes; and (c) Western analysis shows reactivity with trypomastigote lysates,
but not epimastigote lysates. These findings are conditional on the fact that most
of our trypomastigote preparations were contaminated with amastigotes. Enrich-
ment of trypomastigotes from amastigotes by percoll gradient centrifugation led to
enrichment of anti-Fl-160 Western blot reactivity of the trypomastigote lysates and
marked diminution of reactivity of amastigote lysates (not shown). Furthermore,
the amastigotes were morphologically distinguishable by immunofluorescence and
did not fluorescewith anti-Fl-160. Antibodies to another recombinant protein stained
amastigotes, and not trypomastigotes, thus, staining the parasites in these prepara-
tions not stained with anti-Fl-160 (not shown). Thus, it is likely that the F1-160 pro-
tein is expressed in a differentiation-specific manner, by transcriptional control, on
trypomastigotes.
That anti-Fl-160 antibodies stained along theflagellum is particularly interesting,
given that the epimastigote flagellum was not stained. This suggests that the mem-
brane overlying the flagellum of the mammalian form is distinct from that of the
insect form. The expression of F1-160 exclusively in the mammalian form mayreflect
a role for specific interaction with mammalian cells.
Also of note is the strong anti-Fl-160 immunofluorescence seen on the 3T3 cells
that are infected with T . cruzi. This suggests that the antigen can be recognized by
the immune system on the surface of infected cells. The antigen was found on 3T3
cells in infected cultures that had no identifiable intracellular parasites, but not on
3T3 cells in uninfected cultures. This could mean the F1-160 antigen is absorbed
onto uninfected cells, as has been shown with extracts of T . cruzi antigens (25). The
source of the absorbed F1-160 antigen could be from antigen shed into the medium,
or after direct interaction with trypomastigotes. As proposed by Hudson and co-
workers (25), the absorption of T . cruzi antigens to uninfected cells may lead to damage
of uninfected cells by the immune response directed to T . cruzi antigens.
Summary
Chagas' disease, caused by Trypanosoma cruzi, is an excellent model for autoim-
mune disease induced by an infectious agent. Transfer of T cells, directed against
crossreactive antigens of T . cruzi and nervous tissue, have been shown to reproduceVAN VOORHIS AND EISEN
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pathology found in chronic Chagas' disease. We used recombinant DNA technology
to characterize one of these crossreactive antigens (F1-160). We have cloned DNA
from T. cruzi, which expresses a protein corresponding to a 160-kD protein found
on the surface of the trypanosome, overlying the flagellum. This clone hybridizes
to a 4.5-kb poly(A)+ RNA that is distributed in a differentiation-specific manner,
suggesting expression of this protein is transcriptionally controlled. Antibodies to
this protein crossreact with a 48-kD mammalian nervous tissue protein found in
sciatic nerve, brain, and myenteric plexi of gut. The myenteric plexi are destroyed
by inflammatory infiltrates in Chagas' disease, leading to the characteristic
megaesophagus and megacolon Chagas' disease pathology. Thus, this antigen is a
candidate antigen for autoimmune mimicry leading to nervous tissue pathology.
We thank Elizabeth Oluoch for technical assistance; Sue Sather and Klaus Petry for their
valuable discussions and assistance; and Carol Langtimm and Debra Jarvis for editorial as-
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